{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:44:22Z","timestamp":1761709462452,"version":"3.41.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671269","81301077"],"award-info":[{"award-number":["81671269","81301077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.brainres.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T07:37:37Z","timestamp":1518593857000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"1687","author":[{"given":"Xinxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.brainres.2018.02.013_b0005","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.0837-12.2012","article-title":"Galpha(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"32","author":"Alcacer","year":"2012","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2018.02.013_b0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s12035-014-8688-7","article-title":"Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys","volume":"50","author":"Azkona","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2018.02.013_b0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuropharm.2013.11.024","article-title":"Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats","volume":"79","author":"Azkona","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.02.013_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.11.047","article-title":"Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model","volume":"612","author":"Bartlett","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.02.013_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2013.09.020","article-title":"Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia","volume":"62","author":"Bastide","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.02.013_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2015.10.013","article-title":"Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia","volume":"85","author":"Bastide","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.brainres.2018.02.013_b0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","article-title":"Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.brainres.2018.02.013_b0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.brainres.2018.02.013_b0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.02.013_b0050","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1523\/JNEUROSCI.0252-10.2010","article-title":"Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.02.013_b0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nbd.2011.10.011","article-title":"Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model","volume":"45","author":"Chagniel","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"45","key":"10.1016\/j.brainres.2018.02.013_b0060","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1523\/JNEUROSCI.2124-15.2015","article-title":"Loss of VGLUT3 produces circadian-dependent hyperdopaminergia and ameliorates motor dysfunction and l-dopa-mediated dyskinesias in a model of Parkinson's disease","volume":"35","author":"Divito","year":"2015","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.brainres.2018.02.013_b0065","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/npp.2013.60","article-title":"alphaCaMKII autophosphorylation controls the establishment of alcohol drinking behavior","volume":"38","author":"Easton","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.02.013_b0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.05.024","article-title":"NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats","volume":"85","author":"El Arfani","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.brainres.2018.02.013_b0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2014.07.007","article-title":"Selective inactivation of striatal FosB\/DeltaFosB-Expressing neurons alleviates L-DOPA-induced dyskinesia","volume":"79","author":"Engeln","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2018.02.013_b0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biopsych.2014.07.019","article-title":"A Role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and FosB expression","volume":"79","author":"Feyder","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.02.013_b0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2017.03.003","article-title":"Dysregulation of BET proteins in levodopa-induced dyskinesia","volume":"102","author":"Figge","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.02.013_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.01.012","article-title":"The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease","volume":"291","author":"Frau","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2018.02.013_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nbd.2015.12.010","article-title":"Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia","volume":"87","author":"Gangarossa","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.02.013_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2015.11.022","article-title":"Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: behavioral, molecular, and synaptic mechanisms","volume":"86","author":"Ghiglieri","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"Pt 6","key":"10.1016\/j.brainres.2018.02.013_b0105","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/brain\/awv096","article-title":"Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans","volume":"138","author":"Herz","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2018.02.013_b0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2015.01.012","article-title":"Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia","volume":"93","author":"Iderberg","year":"2015","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.brainres.2018.02.013_b0115","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1073\/pnas.1503310112","article-title":"IRBIT regulates CaMKIIalpha activity and contributes to catecholamine homeostasis through tyrosine hydroxylase phosphorylation","volume":"112","author":"Kawaai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.02.013_b0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroscience.2015.04.021","article-title":"Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"298","author":"Keber","year":"2015","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.brainres.2018.02.013_b0125","doi-asserted-by":"crossref","first-page":"e45323","DOI":"10.1371\/journal.pone.0045323","article-title":"Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability","volume":"7","author":"Klug","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2018.02.013_b0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2009.12.027","article-title":"Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat","volume":"38","author":"Lebel","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2018.02.013_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26103","article-title":"Presynaptic effects of levodopa and their possible role in dyskinesia","volume":"30","author":"Mosharov","year":"2015","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.brainres.2018.02.013_b0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-4159.2010.06788.x","article-title":"PKC links Gq-coupled receptors to DAT-mediated dopamine release","volume":"114","author":"Opazo","year":"2010","journal-title":"J. Neurochem."},{"issue":"35","key":"10.1016\/j.brainres.2018.02.013_b0145","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.1523\/JNEUROSCI.0864-14.2014","article-title":"Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease","volume":"34","author":"Park","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.02.013_b0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.02.013","article-title":"Gadd45beta ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model","volume":"89","author":"Park","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2018.02.013_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26955","article-title":"Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice","author":"Perez","year":"2017","journal-title":"Mov. Disord."},{"issue":"23","key":"10.1016\/j.brainres.2018.02.013_b0160","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1523\/JNEUROSCI.1224-04.2004","article-title":"Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism","volume":"24","author":"Picconi","year":"2004","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2018.02.013_b0165","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ana.24375","article-title":"Dual kappa-agonist\/mu-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease","volume":"77","author":"Potts","year":"2015","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2018.02.013_b0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2011.07.042","article-title":"Sustained-release formulation of levodopa methyl ester\/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats","volume":"502","author":"Ren","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.brainres.2018.02.013_b0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2014.03.023","article-title":"Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice","volume":"77","author":"Ruiz-DeDiego","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2018.02.013_b0180","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S1353-8020(09)70784-9","article-title":"The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease","volume":"15","author":"Stocchi","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.brainres.2018.02.013_b0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0026-895X(25)09849-9","article-title":"Correlation of activation of Ca2+\/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells","volume":"46","author":"Tsutsui","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"29","key":"10.1016\/j.brainres.2018.02.013_b0190","doi-asserted-by":"crossref","first-page":"13159","DOI":"10.1073\/pnas.1003432107","article-title":"Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats","volume":"107","author":"Ulusoy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.02.013_b0195","first-page":"341","article-title":"Levodopa\/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats","volume":"6","author":"Yang","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.brainres.2018.02.013_b0200","first-page":"2077","article-title":"Controlled-release levodopa methyl ester\/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats","volume":"7","author":"Yang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.brainres.2018.02.013_b0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.expneurol.2015.05.007","article-title":"Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"271","author":"Yang","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2018.02.013_b0210","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1038\/srep06811","article-title":"Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:36:32Z","timestamp":1751402192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":42,"alternative-id":["S0006899318300714"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.02.013","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}